Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDeferred TaxesDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Crescent Capital BDC (FCRX) Gains from Investment Securities (2022 - 2025)

Historic Gains from Investment Securities for Crescent Capital BDC (FCRX) over the last 4 years, with Q3 2025 value amounting to -$116000.0.

  • Crescent Capital BDC's Gains from Investment Securities changed N/A to -$116000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 1968.5%. This contributed to the annual value of $1.3 million for FY2024, which is 10180.45% up from last year.
  • Per Crescent Capital BDC's latest filing, its Gains from Investment Securities stood at -$116000.0 for Q3 2025.
  • Crescent Capital BDC's 5-year Gains from Investment Securities high stood at $1.7 million for Q1 2025, and its period low was -$116000.0 during Q3 2025.
  • Over the past 4 years, Crescent Capital BDC's median Gains from Investment Securities value was $454500.0 (recorded in 2022), while the average stood at $696625.0.
  • Per our database at Business Quant, Crescent Capital BDC's Gains from Investment Securities crashed by 6677.12% in 2023 and then surged by 13811.32% in 2024.
  • Crescent Capital BDC's Gains from Investment Securities (Quarter) stood at $379000.0 in 2022, then crashed by 64.38% to $135000.0 in 2023, then plummeted by 40.74% to $80000.0 in 2024, then tumbled by 245.0% to -$116000.0 in 2025.
  • Its Gains from Investment Securities stands at -$116000.0 for Q3 2025, versus $1.7 million for Q1 2025 and $80000.0 for Q4 2024.